Revolution Medicines, Inc. RVMD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

45/100

1/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Revolution Medicines, Inc. (RVMD), dont 7 achats et 39 ventes. Le total des achats d'initiés s'élève à $37.72M et le total des ventes d'initiés à $12.93M.

Les initiés notables ayant une activité récente comprennent Mancini Anthony, Sandler Alan B., Cislini Jeff. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — RVMD

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-25	Mancini Anthony	See Remarks	Vente Informative	400	$97.21	$38.88K	54,400
2026-03-20	Sandler Alan B.	Chief Development Officer	Inconnu	11,700	$102.02	$1.19M	-
2026-03-20	Mancini Anthony	See Remarks	Inconnu	26,200	$102.02	$2.67M	-
2026-03-19	Cislini Jeff	General Counsel	Vente Informative	1,163	$97.44	$113.32K	58,518
2026-03-17	Goldsmith Mark A	See Remarks	Vente Informative	12,871	$99.48	$1.28M	276,698
2026-03-17	Horn Margaret A	Chief Operating Officer	Vente Informative	4,583	$99.48	$455.92K	157,570
2026-03-17	Kelsey Stephen Michael	See Remarks	Vente Informative	4,302	$99.48	$427.96K	295,398
2026-03-17	Anders Jack	Chief Financial Officer	Vente Informative	2,753	$99.48	$273.87K	125,512
2026-03-17	Wang Xiaolin	See Remarks	Vente Informative	2,010	$99.48	$199.96K	116,063
2026-03-17	Wei Lin	Chief Medical Officer	Vente Informative	2,073	$99.48	$206.22K	101,366
2026-03-17	Cislini Jeff	General Counsel	Vente Informative	1,795	$99.48	$178.57K	59,681
2026-03-04	Anderson Elizabeth M	Director	Don (Donné)	15,000	-	-	8,215
2026-03-02	Goldsmith Mark A	See Remarks	Exercice d'Options (Vente)	30,000	$4.09	$122.7K	47,708
2026-03-01	Goldsmith Mark A	See Remarks	Attribution de RSU	128,600	$102.02	$13.12M	128,600
2026-03-01	Horn Margaret A	Chief Operating Officer	Attribution de RSU	47,600	$102.02	$4.86M	47,600
2026-03-01	Kelsey Stephen Michael	See Remarks	Attribution de RSU	47,600	$102.02	$4.86M	47,600
2026-03-01	Anders Jack	Chief Financial Officer	Attribution de RSU	45,400	$102.02	$4.63M	45,400
2026-03-01	Wang Xiaolin	See Remarks	Attribution de RSU	34,000	$102.02	$3.47M	34,000
2026-03-01	Wei Lin	Chief Medical Officer	Attribution de RSU	34,000	$102.02	$3.47M	34,000
2026-03-01	Cislini Jeff	General Counsel	Attribution de RSU	32,500	$102.02	$3.32M	32,500
2026-02-06	Goldsmith Mark A	See Remarks	Exercice d'Options (Vente)	24,010	$0.54	$12.97K	144,493
2026-01-21	Cislini Jeff	General Counsel	Vente Informative	908	$115.60	$104.96K	46,976
2026-01-07	Horn Margaret A	Chief Operating Officer	Exercice d'Options (Vente)	51,406	$42.45	$2.18M	1,094
2026-01-07	Anders Jack	Chief Financial Officer	Exercice d'Options (Vente)	10,000	$42.45	$424.5K	15,900
2025-12-16	Goldsmith Mark A	See Remarks	Vente Informative	15,394	$76.82	$1.18M	232,469
2025-12-16	Horn Margaret A	Chief Operating Officer	Vente Informative	4,847	$76.82	$372.33K	141,053
2025-12-16	Kelsey Stephen Michael	See Remarks	Vente Informative	5,447	$76.82	$418.42K	278,600
2025-12-16	Anders Jack	Chief Financial Officer	Vente Informative	3,104	$77.09	$239.29K	108,065
2025-12-16	Cislini Jeff	General Counsel	Vente Informative	2,688	$76.82	$206.48K	47,884
2025-11-25	Goldsmith Mark A	See Remarks	Vente Informative	3,000	$75.00	$225K	67,424
2025-11-25	Anders Jack	Chief Financial Officer	Exercice d'Options (Vente)	5,418	$17.00	$92.11K	-
2025-11-18	Goldsmith Mark A	See Remarks	Exercice d'Options (Vente)	20,000	$4.09	$81.8K	137,708
2025-11-18	Cislini Jeff	General Counsel	Exercice d'Options (Vente)	13,388	$42.45	$568.32K	-
2025-11-12	Goldsmith Mark A	See Remarks	Don (Reçu)	50,000	-	-	54,498
2025-11-12	Goldsmith Mark A	See Remarks	Exercice d'Options (Vente)	20,000	$4.09	$81.8K	157,708
2025-11-11	Anders Jack	Chief Financial Officer	Exercice d'Options (Vente)	10,000	$17.00	$170K	5,418
2025-11-07	Goldsmith Mark A	See Remarks	Exercice d'Options (Vente)	26,479	$1.12	$29.66K	-
2025-10-13	Kelsey Stephen Michael	See Remarks	Vente Informative	25,000	$48.54	$1.21M	284,047
2025-06-20	Cislini Jeff	General Counsel	Vente Informative	1,912	$39.61	$75.74K	54,093
2025-06-16	Goldsmith Mark A	See Remarks	Vente Informative	13,496	$39.83	$537.55K	428,720
2025-06-16	Horn Margaret A	Chief Operating Officer	Vente Informative	3,510	$39.83	$139.8K	150,675
2025-06-16	Kelsey Stephen Michael	See Remarks	Vente Informative	4,289	$39.83	$170.83K	289,414
2025-06-16	Anders Jack	Chief Financial Officer	Vente Informative	2,170	$39.83	$86.43K	113,314
2025-06-16	Wei Lin	Chief Medical Officer	Vente Informative	2,173	$39.83	$86.55K	90,499
2025-06-16	Cislini Jeff	General Counsel	Vente Informative	1,878	$39.83	$74.8K	56,005
2025-03-20	Cislini Jeff	General Counsel	Vente Informative	2,041	$38.71	$79.01K	57,723
2025-03-17	Goldsmith Mark A	See Remarks	Vente Informative	11,738	$39.04	$458.26K	441,564
2025-03-17	Horn Margaret A	Chief Operating Officer	Vente Informative	3,058	$39.04	$119.39K	153,533
2025-03-17	Kelsey Stephen Michael	See Remarks	Vente Informative	3,294	$39.04	$128.6K	293,051
2025-03-17	Anders Jack	Chief Financial Officer	Vente Informative	1,864	$39.04	$72.77K	115,006

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration